Table: Oncolys Biopharma -2019 parent results
Feb 7 (Reuters)-
Oncolys Biopharma Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2019 Dec 31, 2018 Dec 31, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.30 168 mln
(+673.5 pct) (-26.4 pct)
Operating loss 511 mln loss 1.25
Recurring loss 539 mln loss 1.23
Net loss 912 mln loss 1.23
EPS loss 65.55 yen loss 104.55 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T